Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04546763 · ClinicalTrials.gov registry record
Study Watch AF Detection At Home
A clinical trial, sponsored by Verily Life Sciences.
- Completed
- Registry status
- 117
- Enrollment target
NCT04546763 is a clinical trial that has completed, run by Verily Life Sciences. The registered enrollment target is 117 participants.
The verdict
NCT04546763 has completed, sponsored by Verily Life Sciences.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
Study Summary
This is a multi-center, prospective, non-randomized study to evaluate the performance of the study watch PPG algorithm in detecting irregular rhythms suggestive of atrial fibrillation (AF) in subjects at risk of having an event of AF in the free living (home) environment.
Interventions
- DEVICE Study Watch
- DEVICE Zio XT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2020-09-03 |
| Est. Completion | 2021-05-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04546763
The ClinicalTrials.gov registry entry for NCT04546763 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Verily Life Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Study Watch is the first listed.
NCT04546763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04546763 about?
NCT04546763 is a clinical study titled "Study Watch AF Detection At Home". This is a multi-center, prospective, non-randomized study to evaluate the performance of the study watch PPG algorithm in detecting irregular rhythms suggestive of atrial fibrillation (AF) in subjects at risk of having an event of AF in the free living (home) environment.
What is the current status of trial NCT04546763?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2020-09-03. Estimated completion is 2021-05-14.
What interventions are being tested in trial NCT04546763?
The interventions under investigation include: Study Watch (DEVICE), Zio XT (DEVICE).
Who is sponsoring clinical trial NCT04546763?
This trial is sponsored by Verily Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.